<DOC>
	<DOCNO>NCT01703520</DOCNO>
	<brief_summary>The objective study investigate potential association finasteride ( MK-0906 ) exposure development breast cancer men reside Denmark , Sweden , Finland , Norway data national registry . The primary hypothesis study previously report increased incidence male breast cancer among finasteride user explain confound factor .</brief_summary>
	<brief_title>Finasteride ( MK-0906 ) Male Breast Cancer - A Register-Based Nested Case-Control Study ( MK-0906-162/2003.021 ) .</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Breast Neoplasms , Male</mesh_term>
	<mesh_term>Finasteride</mesh_term>
	<criteria>Participant 's study medical information available populationbased health medical registry , prescription registry , mortality registry Denmark , Finland , Norway , Sweden within observation period 1995 2013 Male breast cancer medical information one 4 countryspecific registry study OR country agematched control men without breast cancer medical information one 4 countryspecific registry Study participant 's exposure finasteride available For country agematched control men without breast cancer Previous cancer diagnosis treatment cancer except nonmelanoma skin cancer Previous prostatectomy Finasteride dutasteride use ( dutasteride drug class finasteride ) within first 6 month registration prescription register ( new user design ) .</criteria>
	<gender>Male</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Males breast cancer</keyword>
	<keyword>Finasteride</keyword>
	<keyword>PROSCAR®</keyword>
	<keyword>PROPECIA®</keyword>
</DOC>